HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

NCT02437110 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

122

Enrollment

NIH

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Darunavir
DRUG: Ritonavir
DRUG: Dolutegravir
DRUG: Tenofovir alafenamide (TAF)

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)